| For: | de’Angelis N, Landi F, Carra MC, Azoulay D. Managements of recurrent hepatocellular carcinoma after liver transplantation: A systematic review. World J Gastroenterol 2015; 21(39): 11185-11198 [PMID: 26494973 DOI: 10.3748/wjg.v21.i39.11185] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i39/11185.htm |
| Number | Citing Articles |
| 1 |
Taizo Hibi, Gonzalo Sapisochin. What is transplant oncology?. Surgery 2019; 165(2) doi: 10.1016/j.surg.2018.10.024
|
| 2 |
Kinga Czarnecka, Paulina Czarnecka, Olga Tronina, Teresa Bączkowska, Magdalena Durlik. Body Mass Index: An Unreliable Adiposity Indicator for Predicting Outcomes of Liver Transplantation Due to Hepatocellular Carcinoma. Gastrointestinal Disorders 2024; 6(3) doi: 10.3390/gidisord6030040
|
| 3 |
Matthew Walton, Ros Wade, Lindsay Claxton, Sahar Sharif-Hurst, Melissa Harden, Jai Patel, Ian Rowe, Robert Hodgson, Alison Eastwood. Selective internal radiation therapies for unresectable early-, intermediate- or advanced-stage hepatocellular carcinoma: systematic review, network meta-analysis and economic evaluation. Health Technology Assessment 2020; 24(48) doi: 10.3310/hta24480
|
| 4 |
Ishaan P. Dharia, Emily A. Leven, Natalia Schmidt, Haley Waite, Pu Ni, M. Isabel Fiel, Marcelo E. Facciuto, Thomas D. Schiano, Lauren T. Grinspan. Risk‐Stratified Surveillance for Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Comparison With the RETREAT‐Guided Surveillance Protocol. Clinical Transplantation 2026; 40(10) doi: 10.1111/ctr.70685
|
| 5 |
Filippo Pelizzaro, Alberto Ferrarese, Martina Gambato, Alberto Zanetto, Francesco Paolo Russo, Giacomo Germani, Marco Senzolo, Mario Domenico Rizzato, Caterina Soldà, Alessandro Vitale, Enrico Gringeri, Umberto Cillo, Patrizia Burra. Hepatocellular carcinoma recurrence after liver transplantation: risk factors, targeted surveillance and management options. Hepatoma Research 2024; doi: 10.20517/2394-5079.2024.107
|
| 6 |
Qiang Zhao, Jinbo Huang, Weixin Luo, Haidong Tan, Regina Wan Ju Wong, Zhiying Liu, Meiting Qin, Jiahao Li, Sarene Koh, Lu-En Wai, Tingting Wang, Jia Dan, Zhiyong Guo, Xiaoshun He. HBV-Specific TCR–T Cell Therapy Combining mRNA Electroporation and Lentiviral Transduction: Treatment Regimen for Recurrent HBV-Related HCC after Liver Transplantation. Clinical Cancer Research 2025; 31(18) doi: 10.1158/1078-0432.CCR-25-1245
|
| 7 |
Yutaka Endo, Yuki Bekki, Roberto Hernandez-Alejandro, Koji Tomiyama. Recent Strategies to Attenuate Hepatocellular Carcinoma Recurrence After Liver Transplantation: A Narrative Review. Cancers 2025; 17(10) doi: 10.3390/cancers17101650
|
| 8 |
Jae-Yoon Kim, Nam-Joon Yi, Yoon Jun Kim, Eui Kyu Chie, Jiyoung Kim, Hyun Hwa Choi, Jaewon Lee, Sola Lee, Su Young Hong, Jeong-Moo Lee, Suk Kyun Hong, YoungRok Choi, Kwang-Woong Lee, Kyung-Suk Suh. Posttransplant sequential adrenal and spine metastasis of hepatocellular carcinoma responsive to combined regorafenib and radiotherapy: a case report. Korean Journal of Transplantation 2023; 37(1) doi: 10.4285/kjt.22.0054
|
| 9 |
Peng Liu, Xin Wang, Huan Liu, Shu-Xian Wang, Qing-Guo Xu, Lin Wang, Xiao Xu, Jin-Zhen Cai. Sirolimus improves the prognosis of liver recipients with hepatocellular carcinoma: A single-center experience. Hepatobiliary & Pancreatic Diseases International 2023; 22(1) doi: 10.1016/j.hbpd.2022.11.010
|
| 10 |
Juliet A. Emamaullee, Mariusz Bral, Glenda Meeberg, Aldo J. Montano-Loza, Vincent G. Bain, Kelly Warren Burak, David Bigam, A. M. James Shapiro, Norman Kneteman. HCV Eradication with Direct-Acting Antivirals Does Not Impact HCC Progression on the Waiting List or HCC Recurrence after Liver Transplantation. Canadian Journal of Gastroenterology and Hepatology 2019; 2019 doi: 10.1155/2019/2509059
|
| 11 |
Okan Akhan, Yasin Sarıkaya, Ali Köksal, Emre Ünal, Türkmen Çiftçi, Devrim Akıncı. Irreversible Electroporation of Recurrent Hepatocellular Carcinoma After Liver Transplantation: Report of Two Cases. CardioVascular and Interventional Radiology 2021; 44(5) doi: 10.1007/s00270-021-02784-7
|
| 12 |
Tatsuki Kusuhara, Hidetoshi Gon, Kazuki Terashima, Shohei Komatsu, Yoshiro Matsuo, Sunao Tokumaru, Hirochika Toyama, Masahiro Kido, Tomoaki Okimoto, Takumi Fukumoto. Comparison of Prognostic Outcomes Between Repeat Liver Resection and Particle Therapy for Patients with Recurrent Hepatocellular Carcinoma. Annals of Surgical Oncology 2025; 32(2) doi: 10.1245/s10434-024-16363-w
|
| 13 |
Volkan Ince, Ersin Gundogan, Kerem Tolan, Cuneyt Kayaalp, Sezai Yilmaz. Resection of Adrenal Metastasis Invading Left Renal Vein Following Living Donor Liver Transplantation for Hepatocellular Carcinoma. Journal of Gastrointestinal Cancer 2020; 51(1) doi: 10.1007/s12029-019-00252-7
|
| 14 |
Bufu Tang, Dandan Guo, Weiliang Hou, Wen Zhang, Wei Zhang, Jingqin Ma, Changyu Li, Guowei Yang, Lin Zhu, Min Li, Xuran Jin, Zhiping Yan, Qianqian Zhao, Yongjie Zhou, Xudong Qu. Transarterial Chemoembolization Modulates the Exosomal miR-32-5p/cGAS-STING Axis Mediated Macrophage Ferroptosis, Triggers Immune Remodeling, and Enhances Anti-PD-1/L1 Efficacy in HCC. Research 2026; 9 doi: 10.34133/research.1096
|
| 15 |
Hidetoshi Nitta, Aline Younès, Nada El‐domiaty, Vincent Karam, Rodolphe Sobesky, Eric Vibert, Audrey Coilly, Teresa Maria Antonini, Eleonora De Martin, Daniel Cherqui, Hideo Baba, Olivier Rosmorduc, René Adam, Didier Samuel, Faouzi Saliba. High trough levels of everolimus combined to sorafenib improve patients survival after hepatocellular carcinoma recurrence in liver transplant recipients. Transplant International 2021; 34(7) doi: 10.1111/tri.13897
|
| 16 |
Parul D. Agarwal, Michael R. Lucey. Management of hepatocellular carcinoma recurrence after liver transplantation. Annals of Hepatology 2022; 27(1) doi: 10.1016/j.aohep.2021.100654
|
| 17 |
Aline Lopes Chagas, Angelo A. Mattos, Márcio A. Diniz, Guilherme E.G. Felga, Ilka F.S.F. Boin, Rita C. M.A. Silva, Renato F. Silva, José H.P. Garcia, Agnaldo S. Lima, Júlio C.U. Coelho, Paulo L. Bittencourt, Venâncio A.F. Alves, Luiz Augusto Carneiro D'Albuquerque, Flair J. Carrilho. Impact of Brazilian expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a multicenter study. Annals of Hepatology 2021; 22 doi: 10.1016/j.aohep.2020.100294
|
| 18 |
Aline L. Chagas, Guilherme E.G. Felga, Marcio A. Diniz, Renato F. Silva, Angelo A. Mattos, Rita C.M.A. Silva, Ilka F.S.F. Boin, José H.P. Garcia, Agnaldo S. Lima, Julio C.U. Coelho, Paulo L. Bittencourt, Venâncio A.F. Alves, Luiz A.C. D’Albuquerque, Flair J. Carrilho. Hepatocellular carcinoma recurrence after liver transplantation in a Brazilian multicenter study: clinical profile and prognostic factors of survival. European Journal of Gastroenterology & Hepatology 2019; 31(9) doi: 10.1097/MEG.0000000000001448
|
| 19 |
Suk Kyun Hong, Kwang‐Woong Lee, Kyung Chul Yoon, Hyo‐Sin Kim, Sung‐Woo Ahn, Hyeyoung Kim, Jeong‐Moo Lee, Jae‐Hyung Cho, Nam‐Joon Yi, Kyung‐Suk Suh. Different prognostic factors and strategies for early and late recurrence after adult living donor liver transplantation for hepatocellular carcinoma. Clinical Transplantation 2019; 33(10) doi: 10.1111/ctr.13703
|
| 20 |
Doga Kahramangil, Ali Zarrinpar, Ilyas Sahin. Immune checkpoint inhibitors in the posttransplant landscape of HCC: A systematic literature review. Liver Transplantation 2026; 32(2) doi: 10.1097/LVT.0000000000000550
|
| 21 |
Federico Piñero, Marcos Thompson, Juan Ignacio Marín, Marcelo Silva. Lenvatinib as first-line therapy for recurrent hepatocellular carcinoma after liver transplantation: Is the current evidence applicable to these patients?. World Journal of Transplantation 2020; 10(11): 297-306 doi: 10.5500/wjt.v10.i11.297
|
| 22 |
Sandeep Arora, Roberta Catania, Amir Borhani, Natally Horvat, Kathryn Fowler, Carla Harmath. HCC: role of pre- and post-treatment tumor biology in driving adverse outcomes and rare responses to therapy. Abdominal Radiology 2021; 46(8) doi: 10.1007/s00261-021-03192-8
|
| 23 |
Mishal Mendiratta-Lala, Anum Aslam, Katherine E. Maturen, Maria Westerhoff, Chris Maurino, Neehar D. Parikh, Yilun Sun, Christopher J. Sonnenday, Erica B. Stein, Kimberly L. Shampain, Ravi K. Kaza, Kyle Cuneo, William Masch, Richard Kinh Gian Do, Theodore S. Lawrence, Dawn Owen. LI-RADS Treatment Response Algorithm: Performance and Diagnostic Accuracy With Radiologic-Pathologic Explant Correlation in Patients With SBRT-Treated Hepatocellular Carcinoma. International Journal of Radiation Oncology*Biology*Physics 2022; 112(3) doi: 10.1016/j.ijrobp.2021.10.006
|
| 24 |
Tao Liu, Qiao Shi, Lei Yang, Shusen Wang, Hongli Song, Zhenglu Wang, Xinnv Xu, Hongsheng Liu, Hong Zheng, Zhongyang Shen. Long non-coding RNAs HERH-1 and HERH-4 facilitate cyclin A2 expression and accelerate cell cycle progression in advanced hepatocellular carcinoma. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08714-7
|
| 25 |
Nada El-domiaty, Faouzi Saliba, Eric Vibert, Vincent Karam, Rodolphe Sobesky, Wafaa Ibrahim, Gabriella Pittau, Oriana Ciacio, Chady Salloum, Khaled Amer, Maysaa A. Saeed, Jihan A. Shawky, Antonio Sa Cunha, Olivier Rosmorduc, Daniel Cherqui, René Adam, Didier Samuel. Early Versus Late Hepatocellular Carcinoma Recurrence After Transplantation: Predictive Factors, Patterns, and Long-term Outcome. Transplantation 2021; 105(8) doi: 10.1097/TP.0000000000003434
|
| 26 |
Hamzah Adwan, Lars Hammann, Thomas J. Vogl. Microwave Ablation of Recurrent Hepatocellular Carcinoma after Curative Surgical Resection. Journal of Clinical Medicine 2023; 12(7) doi: 10.3390/jcm12072560
|
| 27 |
Qianying Lao, Xuanyu Wu, Xinxin Zheng, Jinwei Hu, Siqi Huang, Danying Li, Yao Du, Na Yang, Huaijun Zhu. Effect of Tacrolimus Time in Therapeutic Range on Postoperative Recurrence in Patients Undergoing Liver Transplantation for Liver Cancer. Therapeutic Drug Monitoring 2024; 46(1) doi: 10.1097/FTD.0000000000001119
|
| 28 |
Xinyu He, Shengjun Xu, Linsong Tang, Sunbin Ling, Xuyong Wei, Xiao Xu. Insights into the history and tendency of liver transplantation for liver cancer: a bibliometric-based visual analysis. International Journal of Surgery 2024; 110(1) doi: 10.1097/JS9.0000000000000806
|
| 29 |
Taiji Tohyama, Katsunori Sakamoto, Kei Tamura, Taro Nakamura, Jota Watanabe, Hiroyuki Wakisaka, Yasutsugu Takada. Pharyngeal metastasis following living-donor liver transplantation for hepatocellular carcinoma: a case report and literature review. World Journal of Surgical Oncology 2020; 18(1) doi: 10.1186/s12957-020-01873-0
|
| 30 |
Tufan Egeli, Tarkan Unek, Anıl Aysal Ağalar, İlkay Tuğba Ünek, Cihan Agalar, Mücahit Özbilgin, Özgül Sağol, Ali Durubey Çevlik, Aylin Bacakoğlu, Mesut Akarsu, Nur Olgun, Yasemin Başbınar, İbrahim Astarcioğlu, Hülya Ellidokuz. Investigation of Cancer Stem Cell Surface Markers In The Tumor Tissues of Patients Who Had Liver Transplantation Due To Hepatocellular Cancer And Evaluation of The Effect of These Markers on Prognosis. Journal of Basic and Clinical Health Sciences 2024; 8(3) doi: 10.30621/jbachs.1521349
|
| 31 |
Silvia Maier, Debora Donnini, Laura De Luca, Claudio Avellini, Leonardo Alberto Sechi, Giorgio Soardo. Hepatocellular metastasis recurrence in liver transplant after treatment with direct antiviral agents. Clinical Journal of Gastroenterology 2020; 13(2) doi: 10.1007/s12328-019-01031-4
|
| 32 |
Lisa Kojima, Miho Akabane, Matthew Murray, Michael Fruscione, Daiki Soma, Abigail Snyder, John McVey, Daniel J. Firl, Roberto Hernandez-Alejandro, Chandrashekhar A. Kubal, James F. Markmann, Federico N. Aucejo, Koji Tomiyama, Shoko Kimura, Kazunari Sasaki. Reappraisal of tacrolimus levels after liver transplant for HCC: A multicenter study toward personalized immunosuppression regimen. Liver Transplantation 2025; 31(3) doi: 10.1097/LVT.0000000000000459
|
| 33 |
Maria C. van Hooff, Milan J. Sonneveld, Jan N. Ijzermans, Michail Doukas, Dave Sprengers, Herold J. Metselaar, Caroline M. den Hoed, Robert A. de Man. External Validation of the RETREAT Score for Prediction of Hepatocellular Carcinoma Recurrence after Liver Transplantation. Cancers 2022; 14(3) doi: 10.3390/cancers14030630
|
| 34 |
Carlo Sposito, Davide Citterio, Matteo Virdis, Carlo Battiston, Michele Droz Dit Busset, Maria Flores, Vincenzo Mazzaferro. Therapeutic strategies for post-transplant recurrence of hepatocellular carcinoma. World Journal of Gastroenterology 2022; 28(34): 4929-4942 doi: 10.3748/wjg.v28.i34.4929
|
| 35 |
Hui Wang, Wei Li. Recent update on comprehensive therapy for advanced hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2021; 13(8): 845-855 doi: 10.4251/wjgo.v13.i8.845
|
| 36 |
Li-Li Lou, Ying Zhang, Xu Huang, Li-Xia Zhang, Hui-Fan Ji, Xu Li, Xiao-Lin Guo. Solitary nasopharynx metastasis from hepatocellular carcinoma after liver transplantation. Medicine 2019; 98(7) doi: 10.1097/MD.0000000000014368
|
| 37 |
Laura P. Frazão, Margarida C. Quaresma, José B. Pereira-Leal, Christophe Duvoux, Joana Cardoso. Hepatocellular Carcinoma Transplant Criteria Show Poor Negative Predictive Value: A Systematic Review and Meta-Analysis. Journal of Personalized Medicine 2025; 15(10) doi: 10.3390/jpm15100449
|
| 38 |
Alexandra M. Adams, Ahmed O. Kaseb, Hop S. Tran Cao. Transplant Oncology. 2025; doi: 10.1016/B978-0-443-21901-6.00003-3
|
| 39 |
|
| 40 |
Maciej Gryziak, Rafał Stec, Krzysztof Woźniak, Benedykt Szczepankiewicz, Maciej Krasnodębski, Michał Grąt, Leszek Kraj. Prognostic factors for hepatocellular carcinoma recurrence after liver transplantation or resection – single-center experience. Heliyon 2024; 10(22) doi: 10.1016/j.heliyon.2024.e40228
|
| 41 |
Brian T. Welch, J. J. Schmitz, A. N. Kurup, T. D. Atwell, M. R. Callstrom, G. Frey, R. Paz-Fumagalli, A. Allen, K. Watt, J. Heimbach, G. D. Schmit. Feasibility and outcomes of percutaneous thermal ablation of hepatocellular carcinoma in a transplanted allograft. Abdominal Radiology 2018; 43(6) doi: 10.1007/s00261-017-1323-0
|
| 42 |
Mehmet Akce, Bassel F. El-Rayes, Tanios S. Bekaii-Saab. Frontline therapy for advanced hepatocellular carcinoma: an update. Therapeutic Advances in Gastroenterology 2022; 15 doi: 10.1177/17562848221086126
|
| 43 |
Paul Boulard, Charlotte Maulat, Ana Cavillon, Fabien Robin, Frederica Dondero, Chady Salloum, Celia Turco, Flavy Breheret, Valérie Paradis, Chetana Lim, Bruno Heyd, Emmanuel Cuellar, Bertrand Suc, Daniel Azoulay, Isabelle Migueres, François Cauchy, Fabrice Muscari. Effect of intraoperative autotransfusion use during liver transplantation for hepatocellular carcinoma on recurrence-free survival: comparative study with propensity score matching. BJS Open 2025; 9(5) doi: 10.1093/bjsopen/zraf101
|
| 44 |
Reimi Suzuki, Ryoichi Goto, Norio Kawamura, Masaaki Watanabe, Yoshikazu Ganchiku, Kanako C Hatanaka, Yutaka Hatanaka, Toshiya Kamiyama, Tsuyoshi Shimamura, Akinobu Taketomi. Efficient multiple treatments including molecular targeting agents in a case of recurrent hepatocellular carcinoma, post-living donor liver transplantation. Clinical Journal of Gastroenterology 2022; 15(4) doi: 10.1007/s12328-022-01643-3
|
| 45 |
Lorenza Rimassa, Nicola Personeni, Carolin Czauderna, Friedrich Foerster, Peter Galle. Systemic treatment of HCC in special populations. Journal of Hepatology 2021; 74(4) doi: 10.1016/j.jhep.2020.11.026
|
| 46 |
Baris Sarici, Burak Isik, Sezai Yilmaz. Management of Recurrent HCC After Liver Transplantation. Journal of Gastrointestinal Cancer 2020; 51(4) doi: 10.1007/s12029-020-00498-6
|
| 47 |
Amelia J. Hessheimer, Ana Magdalena Vargas-Martínez, Marta Trapero-Bertrán, Miquel Navasa, Constantino Fondevila. Posttransplant Hepatocellular Carcinoma Surveillance. Annals of Surgery 2023; 277(2) doi: 10.1097/SLA.0000000000005295
|
| 48 |
Shruthi H.S. Reddy, Neil Mehta, Jennifer L. Dodge, Abdul R. Hakeem, Shirin E. Khorsandi, Wayel Jassem, Hector Vilca-Melendez, Miriam Cortes-Cerisuelo, Parthi Srinivasan, Andreas Prachalias, Michael A. Heneghan, Varuna Aluvihare, Abid Suddle, Rosa Miquel, Mohamed Rela, Nigel D. Heaton, Krishna V. Menon. Liver transplantation for HCC: validation of prognostic power of the RETREAT score for recurrence in a UK cohort. HPB 2022; 24(5) doi: 10.1016/j.hpb.2021.09.008
|
| 49 |
Silvia Liu, Michael A. Nalesnik, Aatur Singhi, Michelle A. Wood‐Trageser, Parmjeet Randhawa, Bao‐Guo Ren, Abhinav Humar, Peng Liu, Yan‐Ping Yu, George C. Tseng, George Michalopoulos, Jian‐Hua Luo. Transcriptome and Exome Analyses of Hepatocellular Carcinoma Reveal Patterns to Predict Cancer Recurrence in Liver Transplant Patients. Hepatology Communications 2022; 6(4) doi: 10.1002/hep4.1846
|
| 50 |
Liang-Cheng Chen, Hon-Yi Lin, Moon-Sing Lee, Wen-Yen Chiou, Li-Wen Huang, Chia-Hui Chew, Feng-Chun Hsu, Shih-Kai Hung. Effectiveness of individual audio-visual coaching, respiratory modulated stereotactic body radiotherapy for localized hepatocellular carcinoma. Tzu Chi Medical Journal 2021; 33(4) doi: 10.4103/tcmj.tcmj_247_20
|
| 51 |
Dimitri Gassmann, Stefan Weiler, Joachim C. Mertens, Cäcilia S. Reiner, Bart Vrugt, Mirjam Nägeli, Joanna Mangana, Beat Müllhaupt, Fabienne Jenni, Benjamin Misselwitz. Liver Allograft Failure After Nivolumab Treatment—A Case Report With Systematic Literature Research. Transplantation Direct 2018; 4(8) doi: 10.1097/TXD.0000000000000814
|
| 52 |
Nicola de’Angelis, Filippo Landi, Marco Nencioni, Anais Palen, Eylon Lahat, Chady Salloum, Philippe Compagnon, Chetana Lim, Charlotte Costentin, Julien Calderaro, Alain Luciani, Cyrille Feray, Daniel Azoulay. Role of Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation. Progress in Transplantation 2016; 26(4) doi: 10.1177/1526924816664083
|
| 53 |
Abhishek Pandey, Deirdre J Cohen. Ipilumumab for Hepatocellular Cancer in a Liver Transplant Recipient, with Durable Response, Tolerance and Without Allograft Rejection. Immunotherapy 2020; 12(5) doi: 10.2217/imt-2020-0014
|
| 54 |
Yuan Zhuang, Yi-Feng He, Dan-Xue Zheng, Shi-Suo Du, Gen-Lai Lin, Qian-Qian Zhao, Zhao-Chong Zeng, Yi-Xing Chen. Safety and efficacy of hypofractionated radiotherapy combined with tyrosine kinase inhibitors in patients with lung metastases after liver transplantation for hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International 2025; 24(5) doi: 10.1016/j.hbpd.2025.07.003
|
| 55 |
Ying-Ying Xu, Ru-Xue Bai, Qing-Rui Zhang, Shuang Zhang, Jun-Hai Zhang, Shi-Yu Du. A comprehensive analysis of GAS2 family members identifies that GAS2L1 is a novel biomarker and promotes the proliferation of hepatocellular carcinoma. Discover Oncology 2024; 15(1) doi: 10.1007/s12672-024-01083-0
|
| 56 |
Lorenza Rimassa, Romano Danesi, Tiziana Pressiani, Philippe Merle. Management of adverse events associated with tyrosine kinase inhibitors: Improving outcomes for patients with hepatocellular carcinoma. Cancer Treatment Reviews 2019; 77 doi: 10.1016/j.ctrv.2019.05.004
|
| 57 |
Yu-Qing Yang, Zhen-Yu Wen, Xiao-Yan Liu, Zhen-Hu Ma, Yan-E Liu, Xue-Ying Cao, Li Hou, Hui Xie. Current status and prospect of treatments for recurrent hepatocellular carcinoma. World Journal of Hepatology 2023; 15(2): 129-150 doi: 10.4254/wjh.v15.i2.129
|
| 58 |
Edoardogregorio Galli, Giorgio Patelli, Federica Villa, Nicole Gri, Chiara Mazzarelli, Iacopo Mangoni, Cristiano Sgrazzutti, Silvia Ghezzi, Andrea Sartore-Bianchi, Luca Saverio Belli, Luciano De Carlis, Angelo Vanzulli, Salvatore Siena, Katia Bencardino. Circulating blood biomarkers for minimal residual disease in hepatocellular carcinoma: A systematic review. Cancer Treatment Reviews 2025; 135 doi: 10.1016/j.ctrv.2025.102908
|
| 59 |
Philip Bredin, Zita Galvin, Grainne M. O’Kane. Role of immunotherapy in managing cancers prior to liver transplantation. Current Opinion in Organ Transplantation 2025; 30(1) doi: 10.1097/MOT.0000000000001187
|
| 60 |
Nadim Mahmud, Binu John, Tamar H. Taddei, David S. Goldberg. Pre‐transplant alpha‐fetoprotein is associated with post‐transplant hepatocellular carcinoma recurrence mortality. Clinical Transplantation 2019; 33(7) doi: 10.1111/ctr.13634
|
| 61 |
Reham Ashour, Hazem Mohamed Zakaria, Hossam Soliman, Mona Saeed Tantawy, Sally Waheed Elkhadry, Ahmed Hamdy, Yasmin AbdelRahman Muhammed omar. Validation of Prognostic Accuracy of the RETREAT Score in Hepatocellular carcinoma recurrence after liver transplantation in an Egyptian cohort. Journal of Liver Transplantation 2026; 21 doi: 10.1016/j.liver.2025.100312
|
| 62 |
Robert R. McMillan, Vatche G. Agopian. The Critically Ill Cirrhotic Patient. 2020; doi: 10.1007/978-3-030-24490-3_13
|
| 63 |
Ranya Selim, Jinyu Zhang, Reena Salgia. Controversies in Hepatocellular Carcinoma. 2025; doi: 10.1007/978-3-031-90225-3_32
|
| 64 |
Sezai Yilmaz, Volkan Ince. The Importance of the Immunosuppressive Regime on Hepatocellular Carcinoma Recurrence After Liver Transplantation. Journal of Gastrointestinal Cancer 2021; 52(4) doi: 10.1007/s12029-021-00716-9
|
| 65 |
Huixin Li, Zhanyu Yang, Ruofan Li, Shichun Lu, Wenping Lu. Regorafenib Combined With Sirolimus Achieves Successful Treatment of Diffuse Double Lung Metastasis After Liver Transplantation in Giant Liver Cancer Beyond Transplantation Criteria: A Case Report. Transplantation Proceedings 2020; 52(2) doi: 10.1016/j.transproceed.2019.12.001
|
| 66 |
Brian Kim, Jeffrey Kahn, Norah A. Terrault. Liver transplantation as therapy for hepatocellular carcinoma. Liver International 2020; 40(S1) doi: 10.1111/liv.14346
|
| 67 |
Darren J. H. Tan, Chloe Wong, Cheng Han Ng, Chen Wei Poh, Sneha Rajiv Jain, Daniel Q. Huang, Mark D. Muthiah. A Meta-Analysis on the Rate of Hepatocellular Carcinoma Recurrence after Liver Transplant and Associations to Etiology, Alpha-Fetoprotein, Income and Ethnicity. Journal of Clinical Medicine 2021; 10(2) doi: 10.3390/jcm10020238
|
| 68 |
Ender Gunes Yegin, Erkan Oymaci, Emrah Karatay, Ahmet Coker. Progress in surgical and nonsurgical approaches for hepatocellular carcinoma treatment. Hepatobiliary & Pancreatic Diseases International 2016; 15(3) doi: 10.1016/S1499-3872(16)60097-8
|
| 69 |
Jia-Shuo Chao, Sen-Lin Zhao, Si-Wen Ou-yang, Yong-Bing Qian, Ai-Qun Liu, Hua-Mei Tang, Lin Zhong, Zhi-Hai Peng, Jun-Ming Xu, Hong-Cheng Sun. Post-transplant infection improves outcome of hepatocellular carcinoma patients after orthotopic liver transplantation. World Journal of Gastroenterology 2019; 25(37): 5630-5640 doi: 10.3748/wjg.v25.i37.5630
|
| 70 |
Mohammad Saeid Rezaee-Zavareh, Soo Young Hwang, Naomy Kim, Hasmik Adetyan, Nguyen H. Tran, Ju Dong Yang. Managing hepatocellular carcinoma recurrence after liver transplantation: emerging role of immune checkpoint inhibitors. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-03226-3
|
| 71 |
Luke P. Trapp, Elliot Y. Koo, Victoria Lee, Jeffrey Yu. Metastatic hepatocellular carcinoma to the sinonasal cavity: A case report and literature review. Otolaryngology Case Reports 2022; 24 doi: 10.1016/j.xocr.2022.100449
|
| 72 |
Marco Maria Pascale, Camilla Marandola, Francesco Frongillo, Erida Nure, Salvatore Agnes. Locoregional and Surgical Treatment of Single-Nodule Hepatocellular Carcinoma Recurrence After Liver Transplantation: A Systematic Review and a Meta-Analysis. Cancers 2025; 17(9) doi: 10.3390/cancers17091501
|
| 73 |
Khalid I. Bzeizi, Maheeba Abdullah, Kota Vidyasagar, Saleh A. Alqahthani, Dieter Broering. Hepatocellular Carcinoma Recurrence and Mortality Rate Post Liver Transplantation: Meta-Analysis and Systematic Review of Real-World Evidence. Cancers 2022; 14(20) doi: 10.3390/cancers14205114
|
| 74 |
Christin Bürger, Miriam Maschmeier, Anna Hüsing-Kabar, Christian Wilms, Michael Köhler, Martina Schmidt, Hartmut H. Schmidt, Iyad Kabar. Achieving Complete Remission of Hepatocellular Carcinoma: A Significant Predictor for Recurrence-Free Survival after Liver Transplantation. Canadian Journal of Gastroenterology and Hepatology 2019; 2019 doi: 10.1155/2019/5796074
|
| 75 |
M. Bina Possatto, E.C. de Ataíde, C.A. Fazzio Escanhoela, T. Sevá-Pereira, R. de Cassia Martins Alves da Silva, H. Felicio, L.R. de Navarro Amado, R. Ferreira da Silva, A. Soares Lima, I.F.S.F. Boin. Factors Related to Hepatocellular Carcinoma Recurrence After Liver Transplantation—A Brazilian Multicenter Study. Transplantation Proceedings 2017; 49(4) doi: 10.1016/j.transproceed.2017.01.055
|
| 76 |
Jing Liang, Yi Bai, Fu-Shuang Ha, Ying Luo, Hui-Ting Deng, Ying-Tang Gao. Combining local regional therapy and systemic therapy: Expected changes in the treatment landscape of recurrent hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2023; 15(1): 1-18 doi: 10.4251/wjgo.v15.i1.1
|
| 77 |
Ahan Bhatt, Jennifer Wu. Immunotherapy for recurrent hepatocellular carcinoma. World Journal of Gastroenterology 2023; 29(15): 2261-2271 doi: 10.3748/wjg.v29.i15.2261
|
| 78 |
Anju G. S. Phoolchund, Salim I. Khakoo. MASLD and the Development of HCC: Pathogenesis and Therapeutic Challenges. Cancers 2024; 16(2) doi: 10.3390/cancers16020259
|
| 79 |
Wenjuan Cai, Zhenglu Wang, Chunfang Wei, Meng Wu, Weiping Zheng, Haiming Zhang, Chenghu Liu, Lei Liu. Prognostic evaluation of NANOG and OCT4 expression for posttransplantation hepatocellular carcinoma recurrence. Journal of Cellular Biochemistry 2019; 120(5) doi: 10.1002/jcb.28128
|
| 80 |
Fan Yang, Yihang Gong, Xiaofang Zheng, Beibei Ni, Jianxi Lu, Xiaoyan Chen, Jintao Cheng, Panlong Li, Cong Du, Yunhao Chen, Yingcai Zhang, Shuhong Yi, Guoying Wang, Qi Zhang, Yang Yang, Wenjie Chen. NK cell infusion is well-tolerated and shows preliminary efficacy in patients with recurrent hepatocellular carcinoma post-liver transplantation : a phase I trial. Journal of Translational Medicine 2026; 24(1) doi: 10.1186/s12967-026-07725-x
|
| 81 |
Abdulahad Al-Ameri, Xiaobo Yu, Shusen Zheng. Predictors of post-recurrence survival in hepatocellular carcinoma patients following liver transplantation: Systematic review and meta-analysis. Transplantation Reviews 2022; 36(1) doi: 10.1016/j.trre.2021.100676
|
| 82 |
Felix J. Krendl, Ruben Bellotti, Gonzalo Sapisochin, Benedikt Schaefer, Herbert Tilg, Stefan Scheidl, Christian Margreiter, Stefan Schneeberger, Rupert Oberhuber, Manuel Maglione. Transplant oncology – Current indications and strategies to advance the field. JHEP Reports 2024; 6(2) doi: 10.1016/j.jhepr.2023.100965
|
| 83 |
Baoxian Liu, Guangliang Huang, Xiaohua Xie, Qiang Zhao, Liya Su, Ming Liu, Xiaoju Li, Jianting Long, Ming Kuang, Xiaoyan Xie. Feasibility and outcomes of percutaneous radiofrequency ablation for intrahepatic recurrent hepatocellular carcinoma after liver transplantation: a single-center experience. International Journal of Hyperthermia 2020; 37(1) doi: 10.1080/02656736.2020.1834154
|
| 84 |
Parissa Tabrizian, Albert Chan, Rebecca Marino, Héloïse Giudicelli, Allan Lam, Manon Allaire. The role of immunotherapy prior to liver transplantation in advanced or down-staged HCC – timing of transplants, selection of patients, and hurdles to overcome with immunosuppression. International Journal of Surgery 2026; 112(1) doi: 10.1097/JS9.0000000000003520
|
| 85 |
Tommaso Giuliani, Eva Montalvá, Javier Maupoey, Andrea Boscá, Ana Hernando, David Calatayud, Vicente Navarro, Angel Rubín, Carmen Vinaixa, Rafael López-Andújar. Recurrence of Hepatocellular Carcinoma after Liver Transplantation: Clinical Patterns and Hierarchy of Salvage Treatments. Digestive Surgery 2024; 41(4) doi: 10.1159/000539460
|
| 86 |
Ronald Samuel, Mohammad Bilal, Ranjana Nawgiri, Shehzad Merwat, Sreeram Parupudi, Praveen Guturu. Recurrence of hepatocellular carcinoma at the porta-hepatis following liver transplantation diagnosed on EUS-FNA. Clinical Journal of Gastroenterology 2019; 12(4) doi: 10.1007/s12328-019-00934-6
|
| 87 |
Chiara Mazzarelli, Francesco Berardi, Alessandra Bonfichi, Marina Clemente, Michele Orlando, Marina Strollo, Luca Saverio Belli. Systemic Treatment for Hepatocellular Carcinoma Recurrence After Liver Transplantation. Current Oncology 2026; 33(3) doi: 10.3390/curroncol33030141
|
| 88 |
Marina Berenguer. Hepatocellular carcinoma and liver transplantation. Revisiones en Cáncer 2025; doi: 10.20960/revcancer.00112
|
| 89 |
文燕 章. Molecular Markers and Recurrence of Hepatocellular Carcinoma after Liver Transplantation. Advances in Clinical Medicine 2019; 9(03) doi: 10.12677/ACM.2019.93047
|
| 90 |
Matthias Ilmer, Markus Guba. Liver Transplant Oncology: Towards Dynamic Tumor-Biology-Oriented Patient Selection. Cancers 2022; 14(11) doi: 10.3390/cancers14112662
|
| 91 |
Takeshi Kurihara, Noboru Harada, Akinari Morinaga, Takahiro Tomiyama, Katsuya Toshida, Yukiko Kosai, Takahiro Tomino, Takeo Toshima, Yoshihiro Nagao, Kazutoyo Morita, Shinji Itoh, Tomoharu Yoshizumi. Predictive Factors for the Resectable Type of Hepatocellular Carcinoma Recurrence After Living Donor Liver Transplant. Transplantation Proceedings 2023; 55(1) doi: 10.1016/j.transproceed.2022.09.031
|
| 92 |
Nicola De Stefano, Alberto Calleri, Angelo Corso Faini, Victor Navarro-Tableros, Silvia Martini, Silvia Deaglio, Damiano Patrono, Renato Romagnoli. Extracellular Vesicles in Liver Transplantation: Current Evidence and Future Challenges. International Journal of Molecular Sciences 2023; 24(17) doi: 10.3390/ijms241713547
|
| 93 |
Atoosa Rabiee, Jennifer B. Miller. HCC in peri-transplant period: What a gastroenterologist needs to know. Clinical Liver Disease 2023; 22(1) doi: 10.1097/CLD.0000000000000071
|
| 94 |
Joao Manzi, Camilla O. Hoff, Raphaella Ferreira, Renata Glehn-Ponsirenas, Gennaro Selvaggi, Akin Tekin, Christopher B. O’Brien, Lynn Feun, Rodrigo Vianna, Phillipe Abreu. Cell-Free DNA as a Surveillance Tool for Hepatocellular Carcinoma Patients after Liver Transplant. Cancers 2023; 15(12) doi: 10.3390/cancers15123165
|
| 95 |
|
| 96 |
A. Bauschke, A. Altendorf-Hofmann, H. Kissler, A. Koch, C. Malessa, U. Settmacher. Validity of eleven prognostic scores with respect to intra- and extrahepatic recurrence of hepatocellular carcinoma after liver transplantation. Journal of Cancer Research and Clinical Oncology 2017; 143(12) doi: 10.1007/s00432-017-2507-2
|
| 97 |
Zhitao Chen, Tielong Wang, Chuanbao Chen, Xitao Hong, Jia Yu, Yihao Ma, Yiwen Guo, Changjun Huang, Xiaoshun He, Weiqiang Ju, Maogen Chen, Irena Ilic. Circulating Tumor Cell Is a Clinical Indicator of Pretransplant Radiofrequency Ablation for Patients with Hepatocellular Carcinoma. Journal of Oncology 2021; 2021 doi: 10.1155/2021/7776389
|
| 98 |
Adam S. Bodzin, Keri E. Lunsford, Daniela Markovic, Michael P. Harlander-Locke, Ronald W. Busuttil, Vatche G. Agopian. Predicting Mortality in Patients Developing Recurrent Hepatocellular Carcinoma After Liver Transplantation. Annals of Surgery 2017; 266(1) doi: 10.1097/SLA.0000000000001894
|
| 99 |
Niccolò Incarbone, Riccardo De Carlis, Leonardo Centonze, Davide Paolo Bernasconi, Maria Grazia Valsecchi, Andrea Lauterio, Luciano De Carlis. The impact of postoperative complications on oncological outcomes of liver transplantation for hepatocellular carcinoma: A competing risk analysis. Digestive and Liver Disease 2023; 55(12) doi: 10.1016/j.dld.2023.05.026
|
| 100 |
Guo Wei, Yong Zhao, Shifeng Feng, Jingsheng Yuan, Gang Xu, Tao Lv, Jian Yang, Lingxiang Kong, Jiayin Yang. Does depressurization of the portal vein before liver transplantation affect the recurrence of HCC? A nested case-control study. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12322-6
|
| 101 |
Wenjie Miao, Pei Nie, Guangjie Yang, Yangyang Wang, Lei Yan, Yujun Zhao, Ting Yu, Mingming Yu, Fengyu Wu, Wei Rao, Zhenguang Wang. An FDG PET/CT metabolic parameter-based nomogram for predicting the early recurrence of hepatocellular carcinoma after liver transplantation. European Journal of Nuclear Medicine and Molecular Imaging 2021; 48(11) doi: 10.1007/s00259-021-05328-w
|
| 102 |
Benoit Schmauch, Sarah S. Elsoukkary, Amika Moro, Roma Raj, Chase J. Wehrle, Kazunari Sasaki, Julien Calderaro, Patrick Sin-Chan, Federico Aucejo, Daniel E. Roberts. Combining a deep learning model with clinical data better predicts hepatocellular carcinoma behavior following surgery. Journal of Pathology Informatics 2024; 15 doi: 10.1016/j.jpi.2023.100360
|
| 103 |
Rishav Agrawal, Anthony J. Choi. Recurrence of Colorectal Cancer After Liver Transplant for Isolated Colorectal Liver Metastases: A Narrative Review. Cancers 2026; 18(9) doi: 10.3390/cancers18091450
|
| 104 |
Nourhan Badwei. Challenges related to clinical decision-making in hepatocellular carcinoma recurrence post-liver transplantation: Is there a hope?. World Journal of Transplantation 2024; 14(3): 96637 doi: 10.5500/wjt.v14.i3.96637
|
| 105 |
Emrah Sahin, Volkan Ince, Tolga T. Sahin, Ramazan Kutlu, Ramazan Pasahan, Sezai Yilmaz. Undetectable Brain Metastasis of Hepatocellular Carcinoma by PET-CT After Liver Transplantation: a Case Report. Journal of Gastrointestinal Cancer 2023; 54(1) doi: 10.1007/s12029-021-00767-y
|
| 106 |
Benjamin V. Tran, Dimitrios Moris, Daniela Markovic, Hamed Zaribafzadeh, Ricardo Henao, Quirino Lai, Sander S. Florman, Parissa Tabrizian, Brandy Haydel, Richard M. Ruiz, Goran B. Klintmalm, David D. Lee, C. Burcin Taner, Maarouf Hoteit, Matthew H. Levine, Umberto Cillo, Alessandro Vitale, Elizabeth C. Verna, Karim J. Halazun, Amit D. Tevar, Abhinav Humar, William C. Chapman, Neeta Vachharajani, Federico Aucejo, Jan Lerut, Olga Ciccarelli, Mindie H. Nguyen, Marc L. Melcher, Andre Viveiros, Benedikt Schaefer, Maria Hoppe-Lotichius, Jens Mittler, Trevor L. Nydam, James F. Markmann, Massimo Rossi, Constance Mobley, Mark Ghobrial, Alan N. Langnas, Carol A. Carney, Jennifer Berumen, Gabriel T. Schnickel, Debra L. Sudan, Johnny C. Hong, Abbas Rana, Christopher M. Jones, Thomas M. Fishbein, Ronald W. Busuttil, Andrew S. Barbas, Vatche G. Agopian. Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US Multicenter HCC Transplant Consortium. Liver Transplantation 2023; 29(7) doi: 10.1097/LVT.0000000000000145
|
| 107 |
Simone Lasagni, Filippo Leonardi, Alessandra Pivetti, Lorenza Di Marco, Federico Ravaioli, Matteo Serenari, Stefano Gitto, Rosina Maria Critelli, Fabiola Milosa, Adriana Romanzi, Serena Mancarella, Francesco Dituri, Mattia Riefolo, Barbara Catellani, Paolo Magistri, Dante Romagnoli, Ciro Celsa, Marco Enea, Nicola de Maria, Filippo Schepis, Antonio Colecchia, Calogero Cammà, Matteo Cescon, Antonietta d’Errico, Fabrizio di Benedetto, Gianluigi Giannelli, Maria Luz Martinez-Chantar, Erica Villa. Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.960808
|
| 108 |
Amirhossein Azhie, Robert C Grant, Michael Herman, Lisa Wang, Jennifer J Knox, Mamatha Bhat. Phase II clinical trial of cabozantinib for the treatment of recurrent hepatocellular carcinoma after liver transplantation. Future Oncology 2022; 18(18) doi: 10.2217/fon-2021-1635
|
| 109 |
Poh Seng Tan, Mark D. Muthiah, Tsingyi Koh, Yee Leong Teoh, Albert Chan, Alfred Kow, Qishi Zheng, Choon Hyuck David Kwon, Guan Huei Lee, Cosmas Rinaldi A. Lesmana, Vanessa de Villa, James Fung, Kieron Lim. Asian Liver Transplant Network Clinical Guidelines on Immunosuppression in Liver Transplantation. Transplantation 2019; 103(3) doi: 10.1097/TP.0000000000002532
|
| 110 |
Maarouf A. Hoteit, Kelley Weinfurtner. Recurrent HCC after liver transplantation: Small steps, while awaiting a breakthrough. Liver Transplantation 2025; 31(4) doi: 10.1097/LVT.0000000000000571
|
| 111 |
Stella Vasileiadou, Stavros Neiros, Filippos F. Karageorgos, Athanasios Kofinas, Ifaistion Palios, Nikolaos Antoniadis, Emmanouil Sinakos, Georgios Tsoulfas. Immunotherapy for Recurrent Hepatocellular Carcinoma After Liver Transplantation: Current Evidence and Challenges. Transplantology 2026; 7(3) doi: 10.3390/transplantology7030020
|
| 112 |
Kyunghye Bang, Andrea Casadei‐Gardini, Changhoon Yoo, Massimo Iavarone, Min‐Hee Ryu, Sook Ryun Park, Hyung‐Don Kim, Young‐In Yoon, Dong‐Hwan Jung, Gil‐Chun Park, Chul‐Soo Ahn, Deok‐Bog Moon, Shin Hwang, Ki‐Hun Kim, Gi‐Won Song, Chiara Mazzarelli, Eleonora Alimenti, Stephen L. Chan, Massimo De Giorgio, Baek‐Yeol Ryoo, Sung‐Gyu Lee. Efficacy and safety of lenvatinib in patients with recurrent hepatocellular carcinoma after liver transplantation. Cancer Medicine 2023; 12(3) doi: 10.1002/cam4.5123
|
| 113 |
Jinliang Duan, Tao Chen, Shaofeng Chen, Zhenglu Wang, Lei Cao, Hong Zheng, Zhongyang Shen. Establishing a novel mouse model of tacrolimus-induced post-transplant hepatocellular carcinoma pulmonary recurrence for transplant oncology. Frontiers in Cell and Developmental Biology 2026; 14 doi: 10.3389/fcell.2026.1796566
|
| 114 |
Rong-Rong Yao, Quan-Bao Zhang, Meng-Xi Ge, Li Li, Jing Li, Xin-Li Zhou, Zheng-Xin Wang, Xiao-Hua Liang. The safety and efficacy of atezolizumab for recurrent primary liver cancer after liver transplantation. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-02299-4
|
| 115 |
O. D. Olisov, I. A. Dzhanyan, M. S. Novruzbekov, V. V. Breder, M. E. Ilinskiy, L. N. Zimina, E. A. Moroz, K. K. Laktionov, V. A. Guliaev, K. N. Lutsyk, K. M. Magomedov. Multidisciplinary approach in hepatocellular carcinoma progression treatment after liver transplantation: the first experience in Russia. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery 2019; 24(4) doi: 10.16931/1995-5464.2019465-73
|
| 116 |
Dong-Sik Kim, Young-In Yoon, Beom Kyung Kim, Ashok Choudhury, Anand Kulkarni, Jun Yong Park, Jongman Kim, Dong Hyun Sinn, Dong Jin Joo, YoungRok Choi, Jeong-Hoon Lee, Ho Joong Choi, Ki Tae Yoon, Sun Young Yim, Cheon-Soo Park, Deok-Gie Kim, Hae Won Lee, Won-Mook Choi, Young Eun Chon, Woo-Hyoung Kang, Jinsoo Rhu, Jae Geun Lee, Yuri Cho, Pil Soo Sung, Han Ah Lee, Ji Hoon Kim, Si Hyun Bae, Jin Mo Yang, Kyung-Suk Suh, Mamun Al Mahtab, Soek Siam Tan, Zaigham Abbas, Ananta Shresta, Shahinul Alam, Anil Arora, Ashish Kumar, Pravin Rathi, Ruveena Bhavani, Charles Panackel, Kuei Chuan Lee, Jun Li, Ming-Lung Yu, Jacob George, Tawesak Tanwandee, Sen-Yung Hsieh, Chee Chien Yong, Mohamed Rela, H. C. Lin, Masao Omata, Shiv Kumar Sarin. Asian Pacific Association for the Study of the Liver clinical practice guidelines on liver transplantation. Hepatology International 2024; 18(2) doi: 10.1007/s12072-023-10629-3
|
| 117 |
Federica Lo Prinzi, Federico Rossari, Antonio De Rosa, Caterina Vivaldi, Masatoshi Kudo, Shigeo Shimose, Goki Suda, Silvia Camera, Silvia Foti, Mario Domenico Rizzato, Francesca Salani, Naoshi Nishida, Tomotake Shirono, Naoya Sakamoto, Laura Passeri, Michele Ferrara, Caterina Soldà, Silvia Cesario, Kazuomi Ueshima, Takashi Niizeki, Takuya Sho, Mara Persano, Francesco Vitiello, Federica Invernizzi, Sara Lonardi, Gianluca Masi, Margherita Rimini, Andrea Casadei Gardini. Efficacy and Safety of Lenvatinib Versus Sorafenib in Recurrent HCC After Liver Transplant: A Multi‐Center Real‐World Study. Hepatology Research 2026; 56(3) doi: 10.1111/hepr.70076
|
| 118 |
Neha Jakhete, Nehna Abdul Majeed, Daniel Maluf, Kirti Shetty. The Role of Liver Transplantation in Hepatocellular Carcinoma. Clinics in Liver Disease 2025; 29(1) doi: 10.1016/j.cld.2024.08.009
|
| 119 |
Young Kyoung You, Jinha Chun, Yoonyoung Choi, Yoonkyoung Woo, Joseph Ahn, Ho Joong Choi. Experience of split liver transplantation from deceased marginal donor: eight adult recipients from four deceased donors. Annals of Liver Transplantation 2022; 2(2) doi: 10.52604/alt.22.0018
|
| 120 |
Miaotong Su, Weixiang Zhong, Zhen Chen, Guohong Zhang. Establishment of Predictive Models for Second Hepatoma Recurrence. Cancer Management and Research 2026; doi: 10.2147/CMAR.S566522
|
| 121 |
Beat Moeckli, Tommy Ivanics, Marco Claasen, Christian Toso, Gonzalo Sapisochin. Recent developments and ongoing trials in transplant oncology. Liver International 2020; 40(10) doi: 10.1111/liv.14621
|
| 122 |
Matthew T. Newman, Rasham Mittal, Dean La Barba, Amandeep Sahota. Remote Hepatocellular Carcinoma Recurrence to Lumbar Spine Post Orthotopic Liver Transplantation—A Report of Two Cases and a Review of the Literature. Transplantation Proceedings 2024; 56(7) doi: 10.1016/j.transproceed.2024.08.017
|
| 123 |
Seong Hee Kang, Hyeki Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Yoon Jun Kim, Nam-Joon Yi, Kwang-Woong Lee, Kyung-Suk Suh, Jung-Hwan Yoon. Efficacy of Sorafenib for the Treatment of Post-Transplant Hepatocellular Carcinoma Recurrence. Journal of Korean Medical Science 2018; 33(45) doi: 10.3346/jkms.2018.33.e283
|
| 124 |
Aswathy R. Devan, Bhagyalakshmi Nair, Manu Kanjoormana Aryan, Vijayastelar B. Liju, Joel Joy Koshy, Bijo Mathew, Arun Valsan, Hoon Kim, Lekshmi R. Nath. Decoding Immune Signature to Detect the Risk for Early-Stage HCC Recurrence. Cancers 2023; 15(10) doi: 10.3390/cancers15102729
|
| 125 |
Iswanto Sucandy, Susannah Cheek, Benjamin J. Golas, Allan Tsung, David A. Geller, James W. Marsh. Longterm survival outcomes of patients undergoing treatment with radiofrequency ablation for hepatocellular carcinoma and metastatic colorectal cancer liver tumors. HPB 2016; 18(9) doi: 10.1016/j.hpb.2016.06.010
|
| 126 |
Shishir K. Maithel, Rongrong Wang, Joanna Harton, Adam Yopp, Shimul A. Shah, Flavio G. Rocha, Sairy Hernandez, Spencer Cheng, Sarika Ogale, Ruoding Tan. Prognostic Significance of Recurrence and Timing of Recurrence on Survival Among Patients with Early-Stage Hepatocellular Carcinoma in U.S. Clinical Practice. Annals of Surgical Oncology 2025; 32(2) doi: 10.1245/s10434-024-16476-2
|
| 127 |
Zhe Yang, Shuo Wang, Xin-Yao Tian, Qin-Fen Xie, Li Zhuang, Qi-Yong Li, Cheng-Ze Chen, Shu-Sen Zheng. Impact of treatment modalities on patients with recurrent hepatocellular carcinoma after liver transplantation: Preliminary experience. Hepatobiliary & Pancreatic Diseases International 2020; 19(4) doi: 10.1016/j.hbpd.2020.06.002
|
| 128 |
Yu-Xue Gao, Qi-Qi Ning, Peng-Xiang Yang, Yuan-Yue Guan, Peng-Xiang Liu, Meng-Lu Liu, Lu-Xin Qiao, Xiang-Hua Guo, Tong-Wang Yang, De-Xi Chen. Recent advances in recurrent hepatocellular carcinoma therapy. World Journal of Hepatology 2023; 15(4): 460-476 doi: 10.4254/wjh.v15.i4.460
|
| 129 |
Ke Shi, Jie Hou, Qun Zhang, Yufei Bi, Xuanwei Zeng, Xianbo Wang. Neutrophil-to-high-density-lipoprotein-cholesterol ratio and mortality among patients with hepatocellular carcinoma. Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1127913
|
| 130 |
Sam E. Grigg, Gino L. Sarri, Paul J. Gow, Neville D. Yeomans. Systematic review with meta‐analysis: sirolimus‐ or everolimus‐based immunosuppression following liver transplantation for hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics 2019; 49(10) doi: 10.1111/apt.15253
|
| 131 |
Meiching Ong, Kang He, Feng Wang, Ziqiang Li, Yipeng Pan, Wenlei Li, Jun Fang, Aibo Mu, Zhaoxian Li, Siyi Zhong, Zebin Zhu, Songming Li, Tielong Wang, Xuanyi Zhu, Shugeng Zhang, Zhiyong Guo, Jinzhen Cai, Jian Xu, Qiang Xia, Shusen Zheng, Guangming Li, Qi Ling. Immune Checkpoint Inhibitor–Based Downstaging Therapy for Hepatocellular Carcinoma. JAMA Oncology 2026; doi: 10.1001/jamaoncol.2026.3901
|
| 132 |
|
| 133 |
Alexander Piening, Alyssa Capizzi, Jeevin Shahi. Stereotactic Body Radiation Therapy for Intrahepatic Graft Recurrences of Hepatocellular Carcinoma After Liver Transplantation: A Report of Two Cases. Cureus 2025; doi: 10.7759/cureus.85536
|
| 134 |
Yuri Boteon, Mauricio Alfredo Flores Carvalho, Rebecca Panconesi, Paolo Muiesan, Andrea Schlegel. Preventing Tumour Recurrence after Liver Transplantation: The Role of Machine Perfusion. International Journal of Molecular Sciences 2020; 21(16) doi: 10.3390/ijms21165791
|
| 135 |
David D. Lee, Gonzalo Sapisochin, Neil Mehta, Andre Gorgen, Kaitlyn R. Musto, Hana Hajda, Francis Y. Yao, David O. Hodge, Rickey E. Carter, Denise M. Harnois. Surveillance for HCC After Liver Transplantation: Increased Monitoring May Yield Aggressive Treatment Options and Improved Postrecurrence Survival. Transplantation 2020; 104(10) doi: 10.1097/TP.0000000000003117
|
| 136 |
Neus Basté Rotllan. Potential use of multikinase inhibitors in immunosuppressed patients with malignancies including thyroid cancer. Cancer Medicine 2022; 11(S1) doi: 10.1002/cam4.5106
|
| 137 |
Angela Hill, Franklin Olumba, William Chapman. Transplantation for Hepatocellular Carcinoma. Surgical Clinics of North America 2024; 104(1) doi: 10.1016/j.suc.2023.09.002
|
| 138 |
Justin A. Steggerda, Steven A. Wisel, Nicholas N. Nissen, Georgios Voidonikolas, Kambiz Kosari. The Role of Laparoscopic Surgery in the Management of Hepatocellular Carcinoma. Current Hepatology Reports 2024; 23(3) doi: 10.1007/s11901-024-00666-3
|
| 139 |
E. R. Virshke, I. A. Dzhanyan, I. V. Pogrebnyakov, V. V. Breder, M. S. Novruzbekov, O. D. Olisov, B. I. Dolgushin. Transarterial Chemoembolization in Therapy of Patients with Recurrence of Hepatocellular Cancer in a Liver Transplant: a Clinical Case. Journal of oncology: diagnostic radiology and radiotherapy 2023; 6(3) doi: 10.37174/2587-7593-2023-6-3-81-89
|
| 140 |
Charles-Henri Wassmer, Maximiliano Gelli, Tiffany Cho Lam Wong, Zhihao Li, Anudari Zorigtbaatar, Rebecca Marino, Laia Aceituno Sierra, René Adam, Albert Chi Yan Chan, Julie Heimbach, Pål Dag Line, Vincenzo Mazzaferro, Gonzalo Sapisochin, Parissa Tabrizian, Arndt Vogel, Christian Toso. The rise of transplant oncology in primary liver cancer and metastatic disease. Hepatology 2026; 84(4) doi: 10.1097/HEP.0000000000001723
|
| 141 |
Jan Lerut. Liver transplantation and liver resection as alternative treatments for primary hepatobiliary and secondary liver tumors: Competitors or allies?. Hepatobiliary & Pancreatic Diseases International 2024; 23(2) doi: 10.1016/j.hbpd.2023.12.001
|
| 142 |
Claudia Maccali, Aline L. Chagas, Ilka Boin, Emilio Quiñonez, Sebastián Marciano, Mario Vilatobá, Adriana Varón, Margarita Anders, Sergio Hoyos Duque, Agnaldo S. Lima, Josemaría Menendez, Martín Padilla‐Machaca, Jaime Poniachik, Rodrigo Zapata, Martín Maraschio, Ricardo Chong Menéndez, Linda Muñoz, Diego Arufe, Rodrigo Figueroa, Alejandro Soza, Martín Fauda, Simone R. Perales, Rodrigo Vergara Sandoval, Carla Bermudez, Oscar Beltran, Isabel Arenas Hoyos, Lucas McCormack, Francisco Juan Mattera, Adrián Gadano, Jose H. Parente García, Claudia Megumi Tani, Luiz Augusto Carneiro D’Albuquerque, Flair J. Carrilho, Marcelo Silva, Federico Piñero. Recurrence of hepatocellular carcinoma after liver transplantation: Prognostic and predictive factors of survival in a Latin American cohort. Liver International 2021; 41(4) doi: 10.1111/liv.14736
|
| 143 |
Claire Durkin, Douglas E. Schaubel, Yuwen Xu, Nadim Mahmud, David E. Kaplan, Peter L. Abt, Therese Bittermann. Induction Immunosuppression Does Not Worsen Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma. Transplantation 2023; 107(7) doi: 10.1097/TP.0000000000004487
|
| 144 |
Zhihao Li, Itsuko Chih-Yi Chen, Leonardo Centonze, Christian T.J. Magyar, Woo Jin Choi, Sachin Shah, Grainne M. O’Kane, Arndt Vogel, Luciano De Carlis, Jan Lerut, Quirino Lai, Neil Mehta, Chao-Long Chen, Gonzalo Sapisochin. Analysis of treatment benefits and prognostic factors for posttransplant HCC recurrence in a large Euro-American-Asian cohort. Liver Transplantation 2025; 31(4) doi: 10.1097/LVT.0000000000000501
|
| 145 |
P. Jonathan Li, Parissa Tabrizian, Darine Daher, Felipe Gaviria, Veeral Ajmera, Eleazar E. Montalvan-Sanchez, Julio A. Gutierrez, Kali Zhou, Fanny Delebecque, Nicole Garcia, Bethany Barrick, Christopher Wong, Lauren Nephew, John Holden, Shravan Dave, Gabriel T. Schnickel, Nicole E. Rich, Sander S. Florman, Gonzalo Sapisochin, Francis Yao, Amit G. Singal, Neil Mehta. A prospective multicenter validation of RETREAT for posttransplantation HCC recurrence prediction. Hepatology 2025; 82(6) doi: 10.1097/HEP.0000000000001297
|
| 146 |
Giuseppe Marrone, Maria Sandrina Leone, Marco Biolato, Antonio Liguori, Giuseppe Bianco, Gabriele Spoletini, Antonio Gasbarrini, Luca Miele, Maurizio Pompili. Therapeutic Approach to Post-Transplant Recurrence of Hepatocellular Carcinoma: Certainties and Open Issues. Cancers 2023; 15(23) doi: 10.3390/cancers15235593
|
| 147 |
|
| 148 |
Imam Bakir Bati, Umut Tuysuz, Elif Eygi. Prognostic Significance of Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score in Liver Transplantation for Hepatocellular Carcinoma. Current Oncology 2025; 32(8) doi: 10.3390/curroncol32080464
|
| 149 |
Mahmoudreza Moein, Bridgette Nixon, Michael Leyderman, Ali Bassir, Brenden Maloney, Abolfazl Jamshidi, Matin Moallem Shahri, Amin Bahreini, Alireza Golkarieh, Reza Saidi. Long-Term Survival and Recurrence in HCC vs. Non-HCC Liver Transplant Recipients: A Two-Decade Longitudinal Analysis. Journal of Clinical and Experimental Hepatology 2025; 15(3) doi: 10.1016/j.jceh.2024.102489
|
| 150 |
Ramin Raul Ossami Saidy, Maximilian Paul Postel, Michael Johannes Pflüger, Wenzel Schoening, Robert Öllinger, Safak Gül-Klein, Moritz Schmelzle, Frank Tacke, Johann Pratschke, Dennis Eurich. Minimization of Immunosuppressive Therapy Is Associated with Improved Survival of Liver Transplant Patients with Recurrent Hepatocellular Carcinoma. Cancers 2021; 13(7) doi: 10.3390/cancers13071617
|
| 151 |
Ximena Parraga, Eyad Abdulrazzak, Ritah R. Chumdermpadetsuk, Marwan Alsaqa, Shanmukh Pavan Lingamsetty, Alan Bonder, Behnam Saberi. Hepatocellular Carcinoma Recurrence After Liver Transplantation: Current Insights and Future Directions. Journal of Clinical Medicine 2025; 14(19) doi: 10.3390/jcm14197009
|
| 152 |
Jianyu Liu, Dexi Chen, Bo Yao, Ge Guan, Chao Liu, Xinmin Jin, Xin Wang, Peng Liu, Yandong Sun, Yunjin Zang. Effects of donor–recipient combinational CYP3A5 genotypes on tacrolimus dosing in Chinese DDLT adult recipients. International Immunopharmacology 2020; 80 doi: 10.1016/j.intimp.2020.106188
|
| 153 |
|
| 154 |
Yongkun Sun, Wen Zhang, Xinyu Bi, Zhengqiang Yang, Yu Tang, Liming Jiang, Feng Bi, Minshan Chen, Shuqun Cheng, Yihebali Chi, Yue Han, Jing Huang, Zhen Huang, Yuan Ji, Liqun Jia, Zhichao Jiang, Jing Jin, Zhengyu Jin, Xiao Li, Zhiyu Li, Jun Liang, Lianxin Liu, Yunpeng Liu, Yinying Lu, Shichun Lu, Qinghua Meng, Zuoxing Niu, Hongming Pan, Shukui Qin, Wang Qu, Guoliang Shao, Feng Shen, Tianqiang Song, Yan Song, Kaishan Tao, Aiping Tian, Jianhua Wang, Wenling Wang, Zhe Wang, Liqun Wu, Feng Xia, Baocai Xing, Jianming Xu, Huadan Xue, Dong Yan, Lin Yang, Jianming Ying, Jingping Yun, Zhaochong Zeng, Xuewen Zhang, Yanqiao Zhang, Yefan Zhang, Jianjun Zhao, Jianguo Zhou, Xu Zhu, Yinghua Zou, Jiahong Dong, Jia Fan, Wan Yee Lau, Yan Sun, Jinming Yu, Hong Zhao, Aiping Zhou, Jianqiang Cai. Systemic Therapy for Hepatocellular Carcinoma: Chinese Consensus-Based Interdisciplinary Expert Statements. Liver Cancer 2022; 11(3) doi: 10.1159/000521596
|
| 155 |
Incheon Kang, Jae Geun Lee, Sung Hoon Choi, Hyun Jeong Kim, Dai Hoon Han, Gi Hong Choi, Myoung Soo Kim, Jin Sub Choi, Soon Il Kim, Dong Jin Joo. Impact of everolimus on survival after liver transplantation for hepatocellular carcinoma. Clinical and Molecular Hepatology 2021; 27(4) doi: 10.3350/cmh.2021.0038
|
| 156 |
Silvia Cesario, Virginia Genovesi, Francesca Salani, Enrico Vasile, Lorenzo Fornaro, Caterina Vivaldi, Gianluca Masi. Evolving Landscape in Liver Transplantation for Hepatocellular Carcinoma: From Stage Migration to Immunotherapy Revolution. Life 2023; 13(7) doi: 10.3390/life13071562
|
| 157 |
Kin Pan Au, Chi Leung Chiang, Albert Chi Yan Chan, Tan To Cheung, Chung Mau Lo, Kenneth Siu Ho Chok. Initial experience with stereotactic body radiotherapy for intrahepatic hepatocellular carcinoma recurrence after liver transplantation. World Journal of Clinical Cases 2020; 8(13): 2758-2768 doi: 10.12998/wjcc.v8.i13.2758
|
| 158 |
Luckshi Rajendran, Tommy Ivanics, Marco PAW Claasen, Hala Muaddi, Gonzalo Sapisochin. The management of post-transplantation recurrence of hepatocellular carcinoma. Clinical and Molecular Hepatology 2022; 28(1) doi: 10.3350/cmh.2021.0217
|
| 159 |
Avin Aggarwal, Helen S. Te, Elizabeth C. Verna, Archita P. Desai. A National Survey of Hepatocellular Carcinoma Surveillance Practices Following Liver Transplantation. Transplantation Direct 2020; 7(1) doi: 10.1097/TXD.0000000000001086
|
| 160 |
Brian I. Shaw, Aaron Lucander, Kadiyala V. Ravindra. Very Late Recurrence of Hepatocellular Carcinoma After Orthotopic Liver Transplantation: Presentation and Management. Transplantation Direct 2019; 5(9) doi: 10.1097/TXD.0000000000000921
|
| 161 |
Ji-Hoon Sim, Kyung-Won Kim, YouSun Ko, Young-Jin Moon, Hye-Mee Kwon, In-Gu Jun, Sung-Hoon Kim, Kyoung-Sun Kim, Jun-Gol Song, Gyu-Sam Hwang. Association between visceral obesity and tumor recurrence in hepatocellular carcinoma recipients undergoing liver transplantation. International Journal of Obesity 2023; 47(12) doi: 10.1038/s41366-023-01367-5
|
| 162 |
Elizabeth C. Verna, Yuval A. Patel, Avin Aggarwal, Archita P. Desai, Catherine Frenette, Anjana A. Pillai, Reena Salgia, Anil Seetharam, Pratima Sharma, Courtney Sherman, Georgios Tsoulfas, Francis Y. Yao. Liver transplantation for hepatocellular carcinoma: Management after the transplant. American Journal of Transplantation 2020; 20(2) doi: 10.1111/ajt.15697
|
| 163 |
Amelia J. Hessheimer, Constantino Fondevila. Posttransplantation HCC Surveillance: Impact on Outcome or Byproduct of Biology?. Transplantation 2020; 104(10) doi: 10.1097/TP.0000000000003140
|
| 164 |
Haris Muhammad, Aniqa Tehreem, Peng-Sheng Ting, Merve Gurakar, Sean Young Li, Cem Simsek, Saleh A. Alqahtani, Amy K. Kim, Ruhail Kohli, Ahmet Gurakar. Hepatocellular Carcinoma and the Role of Liver Transplantation: A Review. Journal of Clinical and Translational Hepatology 2021; 0(000) doi: 10.14218/JCTH.2021.00125
|
| 165 |
Letizia Todeschini, Luca Cristin, Alessandro Martinino, Amelia Mattia, Salvatore Agnes, Francesco Giovinazzo. The Role of mTOR Inhibitors after Liver Transplantation for Hepatocellular Carcinoma. Current Oncology 2023; 30(6) doi: 10.3390/curroncol30060421
|
| 166 |
2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II Recommendations. Journal of Clinical and Experimental Hepatology 2020; 10(1) doi: 10.1016/j.jceh.2019.09.007
|
| 167 |
Filippo Pelizzaro, Martina Gambato, Enrico Gringeri, Alessandro Vitale, Umberto Cillo, Fabio Farinati, Patrizia Burra, Francesco Paolo Russo. Management of Hepatocellular Carcinoma Recurrence after Liver Transplantation. Cancers 2021; 13(19) doi: 10.3390/cancers13194882
|
| 168 |
Yong Hu, Yong‐Kang Zhou, Yi‐Xing Chen, Lu‐Xi Ye, Zhao‐Chong Zeng. Does liver resection/transplantation affect respiratory induced liver motion in patients with hepatocellular carcinoma?. Journal of Applied Clinical Medical Physics 2017; 18(4) doi: 10.1002/acm2.12113
|
| 169 |
Daniel Hoffman, Neil Mehta. Recurrence of hepatocellular carcinoma following liver transplantation. Expert Review of Gastroenterology & Hepatology 2021; 15(1) doi: 10.1080/17474124.2021.1823213
|
| 170 |
Norma Arteiro Filgueira. Hepatocellular carcinoma recurrence after liver transplantation: Risk factors, screening and clinical presentation. World Journal of Hepatology 2019; 11(3): 261-272 doi: 10.4254/wjh.v11.i3.261
|
| 171 |
Yung-Chi Lai, Kuo-Chen Wu, Chao-Jen Chang, Yi-Jin Chen, Kuan-Pin Wang, Long-Bin Jeng, Chia-Hung Kao. Predicting Overall Survival with Deep Learning from 18F-FDG PET-CT Images in Patients with Hepatocellular Carcinoma before Liver Transplantation. Diagnostics 2023; 13(5) doi: 10.3390/diagnostics13050981
|
| 172 |
Prithiviraj Nabi, Ashwin Rammohan, Mohamed Rela. Living Donor Liver Transplantation for Hepatocellular Carcinoma. Journal of Clinical and Experimental Hepatology 2024; 14(6) doi: 10.1016/j.jceh.2024.101933
|
| 173 |
Federica Invernizzi, Massimo Iavarone, Claudio Zavaglia, Stefano Mazza, Umberto Maggi, Lucia Cesarini, Barbara Antonelli, Aldo Airoldi, Matteo Angelo Manini, Angelo Sangiovanni, Giorgio Rossi, Maria Francesca Donato, Luca Saverio Belli, Pietro Lampertico. Experience With Early Sorafenib Treatment With mTOR Inhibitors in Hepatocellular Carcinoma Recurring After Liver Transplantation. Transplantation 2020; 104(3) doi: 10.1097/TP.0000000000002955
|
| 174 |
Michelle R. Ju, Adam C. Yopp. Evolving thresholds for liver transplantation in hepatocellular carcinoma: A Western experience. Annals of Gastroenterological Surgery 2020; 4(3) doi: 10.1002/ags3.12316
|
| 175 |
Jian-Min Qin. Postoperative recurrent factors and therapeutic and preventive strategies for hepatocellular carcinoma. World Chinese Journal of Digestology 2019; 27(23) doi: 10.11569/wcjd.v27.i23.1407
|